Cognitive Deficiency in Cannabis Consumers

Wurgan Rahadian, Abraham Sabda Respati, Supra Wimbarti, Sri Koesrohmaniah
(Submitted 7 September 2020)
(Published 2 December 2021)


While being the most abused psychoactive substance (PS), cannabis is also the least researched PS (especially) in Indonesia. Since 24% of total PS abusers within the last year is students, we could only form an a priori on what cannabis consumption might lead to for the cognitive functions of the students. A study to explore what would happen to cognitive functions due to cannabis consumption is important. This article aims (1) to explore the effects induced by cannabis to human cognitive functions and (2) to explore which part of the brain correlated with cognitive functions affected by cannabis consumption. We conduct a literature review to answer the questions. This article shows that there is no clear conclusion whether cannabis induced positive or negative effects to human cognitive functions. It is due to various sampling technique used by the studies cited within this article. Several rationalizations stated to support our finding.


cannabis; cognitive functions; neurocognitive

Full Text: PDF

DOI: 10.22146/buletinpsikologi.59576


Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987). Cannabis and Schizophrenia: A Longitudinal Study of Swedish Conscripts. The Lancet, 330(8574), 1483-1486.

Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis Use in Adolescence and Risk for Adult Psychosis: Longitudinal Perspective Study. British Medical Journal, 325(7374), 1212-1213.

Atakan, Z., Bhattacharyya, S., Allen, P., Martín-Santos, R., Crippa, J. A., Borgwardt, S. J., . . . McGuire, P. (2013). Cannabis Affects People Differently: Inter-Subject Variation in the Psychotogenic Effects of Δ9-Tetrahydrocannabinol: a Functional Magnetic Resonance Imaging Study with Healthy Volunteers. Psychological Medicine, 43(6), 1255-1267.

Balhara, Y. P., & Jain, R. (2014). Cannabis Use Among Opioid-Dependent Individuals on Opioid Substitution Therapy. Journal of Pharmacology and Pharmacotherapeutics, 5(3), 203-205.

Bassavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017). Endocannabinoid System in Neurodegenerative Disorders. Journal of Neurochemistry, 142(5), 624-648.

Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., Nosarti, C., O’Carroll, C., . . . McGuire, P. (2009). Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol: A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis. Archives of General Psyciatry, 66(4), 442-451.

Blakemore, S. -J. (2008). The Social Brain in Adolescence. Nature Reviews Neuroscience, 9(4), 267-277.

Blakemore, S. -J., & Choudhury, S. (2006). Development of the Adolescent Brain: Implications for Executive Function and Social Cognition. Journal of Child Psychology and Psychiatry, 47(3-4), 296-312.

Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., . . . McGuire, P. K. (2008). Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition. Biological Psychiatry, 64(11), 966-973.

Bossong, M. G., Jager, G., van Hell, H. H., Zuurman, L., Jansma, J. M., Mehta, M. A., . . . Ramsey, N. F. (2012a). Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study. Journal of Cognitive Neuroscience, 24(3), 588-599.

Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013b). Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function. PloS ONE, 8(7), e70074.

Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., . . . Ramsey, N. F. (2012b). Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function. Biological Psychiatry, 71(8), 693-699.

Bossong, M. G., van Hell, H. H., Jager, G., Kahn, R. S., Ramsey, N. F., & Jasma, M. (2013a). The Endocannabinoid System and Emotional Processing: A Pharmacological fMRI Study with Δ9-Tetrahydrocannabinol. European Neuropsychopharmacology, 23(12), 1687-1697.

Bush, G., & Shin, L. (2006). The Multi-Source Interference Task: an fMRI Task that Reliably Activates the Cingulo-Frontal-Parietal Cognitive/Attention Network. Nature Protocols, 1(1), 308-313.

Carter, R., Aldridge, S., Page, M., & Parker, S. (2019). The Human Brain Book (3rd ed.). NY, USA: DK Publishing.

Cassano, T., Calcagnini, S., Pace, L., De Marco, F., Romano, A., & Gaetani, S. (2017). Cannabinoid Receptor 2 Signalling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. Frontiers in Neuroscience, 11, 30. doi:doi: 10.3389/fnins.2017.00030

Deutsch, D. G., & Chin, S. A. (1993). Enzymatic Synthesis and Degradation of Anandamide, A Cannabinoid Receptor Agonist. Biochemical Pharmacology, 46(5), 791-796. doi:

Diamond, A. (2013). Executive Functions. Annual Review of Psychology, 64, 135-168. doi:doi:10.1146/annurev-psych-113011-143750

Emmet, D., & Nice, G. (2009). What You Need to Know About Cannabis: Understanding the Facts. London, UK: Jessica Kingsley Publishers.

Evren, C. (2017). Cannabis Use and Cognitive Function. In V. R. Preedy, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 70-78). London, UK: Academic Press.

Fernández-Ruiz, J., Gómez-Ruiz, M., García, G., Hernández, M., & Ramos, J. A. (2017). Modelling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies. Methods in Enzymology, 593, 175-198. doi:

Fernández-Ruiz, J., Romero, J., & Ramos, J. A. (2015). Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. In R. G. Pertwee, Endocannabinoids (pp. 233-259). Cham, Switzerland: Springer International Publishing Switzerland.

Gibbs, S. E., & D'Esposito, M. (2005). Individual Capacity Differences Predict Working Memory Performance and Prefrontal Activity Following Dopamine Receptor Stimulation. Cognitive, Affective, & Behavioral Neuroscience, 5(2), 212-221.

Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-Acute (Residual) Neurocognitive Effects of Cannabis Use: A Meta-Analytic Study. Journal of the International Neuropsychological Society, 9(5), 679-689.

Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Gonenc, A., Smith, R. T., Lambros, A. M., . . . Lukas, S. E. (2018). The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Frontiers in Pharmacology, 8, 983.

Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M. T., Smith, R. T., & Lukas, S. E. (2016). Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. Frontiers in Pharmacology, 7, 355.

Holgado, M. A., Martín-Banderas, L., Álvarez-Fuentes, J., & Fernández-Arévalo, M. (2017). Neuroprotective Effect of Cannabinoids Nanoplatforms in Neurodegenerative Diseases. Journal of Drug Delivery Science and Technology, 42, 84-93.

Iseger, T. A., & Bossong, M. G. (2015). A Systematic Review of the Antipsychotic Properties of Cannabidiol in Humans. Schizophrenia Research, 162(1-3), 153-161.

Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., . . . Arinami, T. (2010). Brain Cannabinoid CB2 Receptor in Schizophrenia. Biological Psychiatry, 67(10), 974-982.

Kloft, L. (2017). The Efficacy of Cannabidiol (CBD) as Potential Antipsychotic Medication. Maastricht Student Journal of Psychology and Neuroscience, 6(1), 1-15.

Konrad, K., Firk, C., & Uhlhaas, P. J. (2013). Brain Development During Adolescence: Neuroscientific Insights Into This Development Period. Deutsches Ärzteblatt International, 110(25), 425-431.

Lau, T., & Schloss, P. (2008). The Cannabinoid CB1 Receptor is Expressed on Serotonergic and Dopaminergic Neurons. European Journal of Pharmacology, 578(2-3), 137-141.

Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., . . . Koethe, D. (2012). Cannabidiol Enhances Anadamide Signaling and Alleviates Symptoms of Schizophrenia. Translational Psychiatry, 2(3), e94.

LGN. (2014). Sekarang Aku, Besok Kamu!: Panduan Hukum Bagi Warga Negara Pengguna Ganja (1 ed.). Tangerang Selatan, Indonesia: LGN.

Mai, L. L., Owl, M. Y., & Kersting, M. P. (2005). The Cambridge Dictionary of Human Biology and Evolution. Cambridge, UK: Cambridge University Press.

Marsicano, G., & Lafenêtre, P. (2009). Roles of the Endocannabinoid System in Learning Memory. In D. Kendall, & S. Alexander, Behavioral Neurobiology of the Endocannabinoid System (pp. 201-230). Berlin, Germany: Springer-Verlag Berlin Heidelberg.

Mateos-Aparicio, P., & Rodriguez-Moreno, A. (2019). The Impact of Studying Brain Plasticity. Frontiers in Cellular Neuroscience, 13, 66. doi:doi: 10.3389/fncel.2019.00066

Mizrahi, R., Watts, J. J., & Tseng, K. Y. (2017). Mechanisms Contributing to Cognitive Deficits in Cannabis Users. Neuropharmacology, 124, 84-88.

Mostofsky, S. H., & Simmonds, D. J. (2008). Response Inhibition and Response Selection: Two Sides of the Same Coin. Journal of Cognitive Neuroscience, 20(5), 751-761.

Oomen, P. P., van Hell, H. H., & Bossong, M. G. (2018). The Acute Effects of Cannabis on Human Executive Function. Behavioural Pharmacology, 29(7), 606-616.

Osborne, A. L., Solowij, N., & Weston-Green, K. (2017). A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia. Neuroscience & Biobehavioral Reviews, 72, 310-324.

Peres, F. F., Almeida, V., & Abilio, V. C. (2017). Cannabidiol: An Overview of Its Antipsychotic Properties. In V. R. Preedy, Handbook of Cannabis and Related Pathologies (pp. 787-794). London, UK: Academic Press.

Piechatzek, M., Indlekofer, F., Daamen, M., Blasmacher, C., Lieb, R., Pfister, H., . . . Schütz, C. G. (2009). Is Moderate Substance Use Associated with Altered Executive Functioning in a Population-Based Sample of Young Adults. Human Psychopharmacology Clinical and Experimental, 24, 650-665.

Pinel, J. P. (2009). Biopsikologi (7th ed.). (H. P. Soetjipto, & S. M. Soetjipto, Trans.) Yogyakarta, Indonesia: Pustaka Pelajar.

PUSLITDATIN BNN RI & PUSLITKES UI. (2017). Survey Nasional Penyalahguna NARKOBA di 34 Provinsi Tahun 2017. Jakarta, Indonesia: BNN RI.

Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., & Moeller, M. R. (2009). Neurocognitive Performance During Acute THC Intoxication in Heavy and Occasional Cannabis Users. Journal of Psychopharmacology, 23(3), 266-277.

Riedel, G., & Davies, S. N. (2005). Cannabinoid Function in Learning, Memory and Plasticity. In R. G. Pertwee, Cannabinoids (pp. 445-477). Belin, Germany: Springer-Verlag Berlin Heidelberg.

Ringen, P. A., Vaskinn, A., Sundet, K., Engh, J. A., Jónsdóttir, H., Simonsen, C., . . . Andreassen, O. A. (2010). Opposite Relationships Between Cannabis Use and Neurocognitive Functioning in Bipolar Disorder and Schizophrenia. Psychological Medicine, 40(8), 1337-1347.

Ross, J. M., Ellingson, J. M., Rhee, S. H., Hewitt, J. K., Corley, R. P., Lessem, J. M., & Friedman, N. P. (2020). Investigating the Causal Effect of Cannabis Use on Cognitive Function with a Quasi-Experimental Co-Twin Design. Drug and Alcohol Dependence, 206, 107712.

Sagar, K. A., & Gruber, S. A. (2018). Interactions Between Recreational Cannabis Use and Cognitive Function: Lesson from Functional Magentic Resonance Imaging. Annals of the New York Academy of Sciences, 1451(1), 42. doi:doi: 10.1111/nyas.13990

Saputro, W. T. (2018). Implementasi Kebijakan Pendayagunaan Tanaman Ganja di Indonesia Melalui UU Narkotika No. 35 Tahun 2009 (Undergraduate Thesis). Jawa Timur, Indonesia: Universitas Brawijaya. Retrieved from

Sawaguchi, T. (2001). The Effects of Dopamine and Its Antagonists on Directional Delay-Period Activity of Prefrontal Neurons in Monkeys During an Oculomotor Delayed-Response Task. Neuroscience Research, 41(2), 115-128.

Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F., Moore, T. M., & Gur, R. C. (2018). Association of Cannabis with Cognitive Functioning in Adolecent and Young Adults: A Systemic Review and Meta-Analysis. JAMA Psychiatry, 75(6), 585-595.

Scott, J. C., Wolf, D. H., Calkins, M. E., Bach, E. C., Weidner, J., Kosha, R., . . . Gur, R. C. (2017). Cognitive Functioning of Adolescent and Young Adult Cannabis Users in Philadelphia Neurodevelopmental Cohort. Psychology of Addictive Behaviors, 31(4), 423-434.

Sestieri, C., Corbetta, M., Romani, G. L., & Shulman, G. L. (2011). Episodic Memory Retrieval, Parietal Cortex, and the Default Mode Network: Functional and Topographic Analyses. Journal of Neuroscience, 31(12), 4407-4420. doi:doi: 10.1523/JNEUROSCI.3335-10.2011.

Singh, S., & Joshi, N. (2019). Preface. In S. Singh, & N. Joshi, Pathology, Prevention and Therapeutics of Neurodegenerative Disease (pp. v-vi). Singapore, Singapore: Springer Nature Singapore Pte Ltd.

Smith, E. E., & Kosslyn, S. M. (2014). Psikologi Kognitif: Pikiran dan Otak. (H. S. Prajitno, & S. M. Soetjipto, Trans.) Yogyakarta, Indonesia: Pustaka Pelajar.

Solowij, N., Broyd, S. J., Beale, C., Prick, J.-.. A., Greenwood, L.-.. M., van Hell, H., . . . Yücel, M. (2018). Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial. Cannabis and Cannabinoid Research, 3(1), 21-34.

Squire, L. R., Stark, C. E., & Clark, C. E. (2004). The Medial Temporal Lobe. Annual Review of Neuroscience, 27, 279-306.

Sujono, A. R., & Daniel, B. (2013). Komentar dan Pembahasan Undang-Undang Nomor 35 Tahun 2009 tentang Narkotika. Jakarta, Indonesia: Sinar Grafika.

(2009). Undang-undang Nomor 35 Tahun 2009 tentang Narkotika.

van Hell, H. H., Bossong, M. G., Jager, G., Kahn, R. S., & Ramsey, N. F. (2011). Methods of Pharmacological Imaging of the Cannabinoid System (PhICS) Study: Towards Understanding the Role of the Brain Endocannabinoid System in Human Cogntion. International Journal of Methods in Psychiatric Research, 20(1), 10-27.

van Hell, H. H., Jager, G., Bossong, M. G., Brouwer, A., Jansma, J. M., Zuurman, L., . . . Ramsey, N. F. (2012). Involvement of the Endocannabinoid System in Reward Processing in the Human Brain. Psychopharmacology, 219(4), 981-990.

Walkey, L. R., Tanguay, R. L., & el-Guebaly, N. (2018). Narrative Review of Cannabidiol as an Antipsychotic and Recommendations for Legal Regulations. Canadian Journal of Addiction, 9(3), 23-29.

Widodo, W., & Surjaningrum, E. R. (2014). Studi Perbandingan Kemampuan Working Memory pada Pecandu Ganja dan Non-Pecandu Ganja. Jurnal Psikologi Klinis dan Kesehatan Mental, 3(2), 72-78.

Wise, R. A., & Rompre, P. P. (1989). Brain Dopamine and Reward. Annual Review of Psychology, 40(1), 191-225.

Wright, N. E., Maple, K. E., & Lisdahl, K. M. (2017). Effects of Cannabis Use on Neurocognition in Adolescents and Emerging Adults. In V. R. Preedy, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 151-159). London, UK: Academic Press.

Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., . . . Sutherland, M. T. (2018). Neuroimaging Meta-Analysis of Cannabis Use Studies Reveals Convergent Functional Alterations in Brain Regions Supporting Cognitive Control and Reward Processing. Journal of Pharmacology, 32(3), 283-295.

Zanettini, C., Panlilio, L. V., Aliczki, M., Goldberg, S. R., Haller, J., & Yasar, S. (2011). Effects of Endocannabinoid System Modulation on Cognitive and Emotional Behavior. Frontiers in Behavioral Neuroscience, 5, 57.


  • There are currently no refbacks.

Copyright (c) 2021 Buletin Psikologi

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.